STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. RANI
  4. [EFFECT] Rani Therapeutics Holdings, Inc. SEC Filing

[EFFECT] Rani Therapeutics Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:00 P.M.
Form: S-3
CIK: 0001856725
Company Name: Rani Therapeutics Holdings, Inc.
File Number: 333-288509

Source: View Original Filing on SEC EDGAR

Stock RANI logo
Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

RANI Rankings

#4540 Ranked by Market Cap
N/A Ranked by Dividends

RANI Latest News

Nov 24, 2025
Rani Therapeutics to Participate in the Evercore Healthcare Conference
Nov 6, 2025
Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update
Oct 30, 2025
Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025
Oct 23, 2025
Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors
Oct 23, 2025
Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

RANI Latest SEC Filings

Nov 7, 2025
[S-3] Rani Therapeutics Holdings, Inc. Shelf Registration Statement
Nov 6, 2025
[10-Q] Rani Therapeutics Holdings, Inc. Quarterly Earnings Report
Nov 6, 2025
[8-K] Rani Therapeutics Holdings, Inc. Reports Material Event
Oct 30, 2025
[Form 3] Rani Therapeutics Holdings, Inc. Initial Statement of Beneficial Ownership
Oct 30, 2025
[Form 4] Rani Therapeutics Holdings, Inc. Insider Trading Activity

RANI Stock Data

158.99M
91.79M
19.56%
17.01%
0.22%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN JOSE